Want to join the conversation?
$VZ expects full-year 2016 adjusted earnings to plateau at a level comparable to its strong full-year 2015 adjusted earnings. $VZ projects adjusted EBITDA margin consistent with full-year 2015, and capital spending of $17.2-17.7Bil. Effective tax rate for financial reporting purposes is predicted to be 35-36%.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.